To evaluate the relevance of the ER peptide trimming inhibition on tumorigenicity, we stably reduced ERAP1 expression in a murine T-cell lymphoma by ERAP1-targeted small interfering RNA. Here, ERAP1 is linked to T-cell non-Hodgkin lymphoma.